Abstract Details

Title MIS416, a myeloid targeted immune modulator for the treatment of secondary progressive multiple sclerosis acts directly within the CNS to induce Type I IFN and suppress neuroinflammation

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 334

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Reza Khorooshi PRESENTER	No disclosure on file
	No disclosure on file
Gill Webster, PhD	No disclosure on file
	No disclosure on file